LONDON—Since its foundation in 2009, the EASL-CLIF Consortium has been devoted to the advancement of knowledge on the pathophysiology, diagnostics, and treatment of cirrhosis.
After the annual meeting of the EASL-CLIF Consortium Steering Committee that took place on 23 June 2022 in London, UK, EF Clif announces the election of one new centers to join the EASL-CLIF Consortium in supporting targeted research and collaborative initiatives with the aim to advance knowledge of liver disease and improve the quality of life of patients with chronic liver disease. Nominated centers are elected based on clinical and research excellence. This year, CHRU Tours–Hôpital Trousseau in France has received this designation with Dr. Laure Elkrief as center coordinator.
Required criteria for nominating centers
General nomination criteria for centers:
• Must be located in Europe
• Must have a strong background in hepatology
• Must have medical facilities for hepatology clinic visits
Nominating centers must submit the following information:
• Presence/absence of inpatient clinic/outpatient clinic/day hospital
• Approximate number of inpatients/outpatients with chronic liver failure visited per year
• Availability of a research laboratory facility
• Availability of an animal facility
• Availability of a biobanking facillity
Nominating Center Coordinators and Principal Investigators must submit the following information:
• Curriculum vitae
• List of publications on chronic liver failure (max. 25)
• Motivation letter
European Foundation for the Study of Chronic Liver Failure
Travessera de Gràcia 11, 7th floor
About the EASL-CLIF Consortium
The EASL-CLIF Consortium supports targeted research and collaborative research initiatives with the aim to advance knowledge of liver disease and improve the quality of life of patients with cirrhosis.
Since its foundation in 2009, the European Association for the Study of the Liver (EASL) Chair supports research activities through the EASL-CLIF Consortium, a network of 116 centers and more than 170 clinical researchers in 28 countries across Europe. Every year, the EASL-CLIF Consortium Steering Committee evaluates applications by university hospitals and tertiary hospitals with an interest to join our network. Membership is granted to centers based on clinical and research excellence.
About EF Clif
The European Foundation for the Study of Chronic Liver Failure (EF Clif) is a private non-profit organization connecting biomedical researchers and healthcare professionals with each other, with patients and patient associations, and with society. The fundamental purpose of EF Clif, reflected in its founding Statements of 2015, is to advance knowledge and promote research and education in liver disease to improve the prognosis of patients living with chronic liver failure.